‘Call for Targets’ of respiratory diseases
2 Mar 2015 by Evoluted New Media
MRC Technology has announced a ‘call for targets’ to find new therapeutics for the treatment of respiratory diseases.
The MRC is looking for academic researchers worldwide to accelerate the treatment development of respiratory conditions by using potential small molecule or antibody targets. The researchers will work with the MRC to validate and prove their concepts before a full scale drug discovery project is initiated.
“Finding treatments for respiratory disease is a clear area of unmet need, with chronic obstructive pulmonary disease being the fifth biggest killer disease in the UK. This latest call for respiratory targets is strongly aligned to our charitable aim of advancing scientific discoveries that can improve human health,” said Justin Bryans, Director of Drug Discovery at MRC Technology.
The MRC offers the opportunity to collaborate with MRC Technology’s Centre for Therapeutic Discovery (CTD). Successful projects will benefit from CTD’s wealth of experience in assay development, high throughput screening, medicinal chemistry, antibody engineering and affinity maturation. The centre will also provide researchers with access to an in-house small molecule library and its core antibody humanisation skills.
Researchers interested visit:
